Cardiac Rhythm Management Market Size and Forecasts by 2031

Cardiac Rhythm Management Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Defibrillators, Pacemakers, Cardiac Resynchronization Therapy Devices); End User (Hospitals, Ambulatory Surgery Centers, Others), and Geography (North America, Europe, Asia Pacific, and South and Central America)

Historic Data: 2021-2023   |   Base Year: 2025   |   Forecast Period: 2025-2031
  • Report Date : Apr 2026
  • Report Code : TIPHE100000850
  • Category : Life Sciences
  • Status : Upcoming
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 150
Cardiac Rhythm Management Market Size and Forecasts by 2031
Report Date: Apr 2026   |   Report Code: TIPHE100000850
Buy Now
Page Updated: Feb 2026

MARKET OVERVIEW

Cardiac Rhythm Management (CRM) is a procedure to manage proper functioning of the heart. CRM can be accomplished using devices such as, defibrillators, pacemakers, and cardiac resynchronization therapy devices among others. CRM helps in accurate monitoring and treatment in patients suffering from heart disease, strokes, and high blood pressure. These CRM devices are used in hospitals, and home & ambulatory care for enhanced treatment.

MARKET SCOPE

The "Global Cardiac Rhythm Management Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the cardiac rhythm management market with detailed market segmentation by product, end user and geography. The report provides key statistics on the market status of the leading cardiac rhythm management market players and offers key trends and opportunities in the market.

Customize This Report To Suit Your Requirement

Get FREE CUSTOMIZATION

Cardiac Rhythm Management Market: Strategic Insights

cardiac-rhythm-management-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

MARKET SEGMENTATION

  • Based on product, the global cardiac rhythm management market is segmented into defibrillators, pacemakers, and cardiac resynchronization therapy devices. The defibrillators is segmented into implantable cardioverter defibrillators (ICDS), and external defibrillators (ED). Pacemakers is segmented into implantable pacemakers (ICPS), and external pacemakers.
  • On the basis of end user, the market is segmented into hospitals, home and ambulatory care, and other.

MARKET DYNAMICS

Drivers

  • Increasing Prevalence of Cardiovascular Disorders
  • Technological Advancements
  • Rise in the Use of Ambulatory and Home Services for Cardiac Monitoring

Restraints

  • High Cost of Devices

Cardiac Rhythm Management Market Report Scope

Report Attribute Details
Market size in 2025 US$ XX Million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 2.5%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Product
  • Defibrillators
  • Pacemakers
  • Cardiac Resynchronization Therapy Devices
By End User
  • Hospitals
  • Ambulatory Surgery Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • General Electric Company
  • BIOTRONIK
  • Medtronic
  • Boston Scientific Corporation
  • Koninklijke Philips N.V.
  • Abbott
  • LivaNova PLC
  • Mortara Instrument
  • Cardiac Science
  • Schiller
  • Abiomed
  • Shenzhen Mindray Biomedical Electronics Co., Ltd
  • Zoll Medical Corporation

Cardiac Rhythm Management Market Players Density: Understanding Its Impact on Business Dynamics

The Cardiac Rhythm Management Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

cardiac-rhythm-management-market-cagr

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The cardiac rhythm management market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region. The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the cardiac rhythm management market in these regions.

IMPACT OF COVID-19 ON CARDIAC RHYTHM MANAGEMENT MARKET

The COVID-19 pandemic has impacted all industries, including cardiac rhythm management market. Market players have experienced decline sales in cardiac rhythm management segments due to the delay in cardiovascular procedures. For instance, in 2021, Medtronic experienced a 12% decrease in its cardiac rhythm management devices segment. The decline was majorly experienced in ICDs, CRT-Ds, and pacemaker segments. Such factors negatively affected the growth of the market for cardiac rhythm management devices.

MARKET PLAYERS

The report covers key developments in the cardiac rhythm management market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from cardiac rhythm management market are anticipated to lucrative growth opportunities in the future with the rising demand for Cardiac Rhythm Management in the global market. The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Cardiac Rhythm Management market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  • ZOLL Medical Corporation
  • BIOTRONIK
  • Medtronic
  • Boston Scientific Corporation
  • Koninklijke Philips N.V.
  • Abbott
  • LivaNova PLC
  • Schiller
  • Abiomed
  • MicroPort Scientific Corporation

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
Chat with us
DUNS Logo
87-673-9708
ISO Certified Logo
ISO 9001:2015
GDPR
CCPA